548 related articles for article (PubMed ID: 16316827)
1. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
2. Immunology. Stress, NK receptors, and immune surveillance.
Pardoll DM
Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
[No Abstract] [Full Text] [Related]
3. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
[TBL] [Abstract][Full Text] [Related]
4. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
5. Natural killer lymphocytes: biology, development, and function.
Papamichail M; Perez SA; Gritzapis AD; Baxevanis CN
Cancer Immunol Immunother; 2004 Mar; 53(3):176-86. PubMed ID: 14685782
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
7. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
Wesa AK; Storkus WJ
Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
[TBL] [Abstract][Full Text] [Related]
8. Porcine T lymphocytes and NK cells--an update.
Gerner W; Käser T; Saalmüller A
Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
10. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
11. [Tgammadelta lymphocytes in oncology: unconventional killer lymphocytes].
Catros V; Toutirais O; Bouet F; Cabillic F; Desille M; Fournié JJ
Med Sci (Paris); 2010 Feb; 26(2):185-91. PubMed ID: 20188051
[TBL] [Abstract][Full Text] [Related]
12. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
[TBL] [Abstract][Full Text] [Related]
13. NKT cells and tumor immunity--a double-edged sword.
Smyth MJ; Godfrey DI
Nat Immunol; 2000 Dec; 1(6):459-60. PubMed ID: 11101862
[No Abstract] [Full Text] [Related]
14. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
15. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
16. Killer dendritic cells and their potential role in immunotherapy.
Ullrich E; Chaput N; Zitvogel L
Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
[TBL] [Abstract][Full Text] [Related]
17. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
[TBL] [Abstract][Full Text] [Related]
18. NKT cells: T lymphocytes with innate effector functions.
Van Kaer L
Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
Liu J; Roederer M
Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
[TBL] [Abstract][Full Text] [Related]
20. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
